Familial hypercholesterolaemia: A global call to arms

Affiliations

• ¹ School of Public Health, Imperial College London, London, UK.
• ² Cardiovascular and Cell Sciences Research Institute, St George's University of London, London, UK.
• ³ Academic Medical Centre, Amsterdam, The Netherlands.
• ⁴ Fundación Hipercolesterolemia Familiar, Madrid, Spain.
• ⁵ Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
• ⁶ Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.
• ⁷ Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK.
• ⁸ Cardiovascular Medicine, Royal Perth Hospital, University of Western Australia, Perth, Australia.
• ⁹ Laboratory of Biochemistry and Molecular Therapeutics, Faculty of Pharmacy, Saint-Joseph University, Beirut, Lebanon.
• ¹⁰ Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
• ¹¹ Global eHealth Unit, School of Public Health, Imperial College London, London, UK.
• ¹² Cardiovascular Prevention and Rehabilitation Unit, Prince Sultan Cardiac Centre Riyadh, Riyadh, Saudi Arabia.
• ¹³ Lipid Clinic, Department of Nutrition, Clínica Las Condes, Santiago de Chile, Chile.
• ¹⁴ Sultan Qaboos University Hospital, Muscat, Oman.
• ¹⁵ Department of Hypertension, Medical University of Lodz, Lodz, Poland.
• ¹⁶ National Advisory Unit on Familial Hypercholesterolemia, Norway.
• ¹⁷ Instituto Nacional de Saúde Doutor Ricardo Jorge and BioISI - Biosystems & Integrative Sciences Institute, Universidade de Lisboa, Portugal.
• ¹⁸ Endocrinologie métabolisme et prevention cardiovasculaire, Institut E3M et IHU cardiométabolique (ICAN), HôpitalPitiéSalpêtrière, Paris, France.
• ¹⁹ Global eHealth Unit, School of Public Health, Imperial College London, London, UK; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
• ²⁰ FASTA University, School of Medicine, Mar del Plata, Argentina.
• ²¹ Hôpital de Jolimont, Haine Saint-Paul, Belgium.
• ²² Austrian Atherosclerosis Society, c/o, Medical University of Innsbruck, Innsbruck, Austria.
• ²³ Hadassah Hebrew University Medical Center, Jerusalem, Israel.
• ²⁴ Centre for Cardiovascular Surgery and Transplantation Brno, and Ceitec, Masaryk University, Brno, Czech Republic.
• ²⁵ Medical Genetics Department, Centro Hospitalar de Lisboa Ocidental and Genetics Laboratory, Lisbon Medical School, University of Lisbon, Portugal.
• ²⁶ McGill University, Montreal, Canada.
• ²⁷ National Cerebral and Cardiovascular Centre Research Institute, Osaka, Japan.
• ²⁸ National Center for Cardiovascular Diseases, Beijing, China.
• ²⁹ Ege University Medical School, Department of Cardiology, Izmir, Turkey.
• ³⁰ National Heart Centre Singapore and Duke-National University of Singapore, Singapore.
• ³¹ Paul Stradins Clinical University Hospital, Latvian Research Institute of Cardiology, University of Latvia, Riga, Latvia.
• ³² Universität des Saarlandes, Homburg, Germany.
• ³³ University of Ioannina Medical School, Ioannina, Greece.
• ³⁴ Department of Medical and Health Sciences, Linkoping University, Linkoping, Sweden.
• ³⁵ Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
• ³⁶ Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
• ³⁷ Deutsches Herzzentrum Munchen, Klinikan der TU Munchen, Munich Heart Alliance, Germany.
• ³⁸ CMHS, UAE University, AlAin, United Arab Emirates.
• ³⁹ Cardiovascular Genetic Laboratory, Cardiovascular Health Commission, Montevideo, Uruguay.
• ⁴⁰ Department of Internal Medicine and Cardiovascular Centre, National Taiwan University Hospital, Taipei, Taiwan.
• ⁴¹ Laboratory of Clinical Lipidology, Cardiology Research Complex, Moscow, Russia.
• ⁴² Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
• ⁴³ University of Milan and Multimedica IRCCS Milan, Italy.
• ⁴⁴ School of Public Health, Imperial College London, London, UK. Electronic address: k.ray@imperial.ac.uk.